KEYNOTE-B15/EV-304: Randomized phase 3 study of perioperative enfortumab vedotin plus pembrolizumab versus chemotherapy in cisplatin-eligible patients with muscle-invasive bladder cancer (MIBC) - Hoimes, CJ; Bedke, J; Loriot, Y (Journal of Clinical Oncology, 2021)